Severe acute respiratory syndrome coronavirus 2 (ID 630714) - BioProject

Format

Choose Destination

Accession: PRJNA630714 ID: 630714

Severe acute respiratory syndrome coronavirus 2

See Genome Information for Severe acute respiratory syndrome-related coronavirus

Navigate Up

This project is a component of the COVID-19 Outbreak

Navigate Across

59 additional projects are components of the COVID-19 Outbreak.

962 additional projects are components of the INSDC SARS-CoV-2 Viral Sequencing Data.

407 additional projects are related by organism.

Whole-genome sequencing of SARS-CoV-2 genomes from clinical samples using a tiled-amplicon approach.

Accession	PRJNA630714
Data Type	Genome sequencing
Scope	Multiisolate
Organism	Severe acute respiratory syndrome coronavirus 2[Taxonomy ID: 2697049] Viruses; Riboviria; Orthornavirae; Pisuviricota; Pisoniviricetes; Nidovirales; Cornidovirineae; Coronaviridae; Orthocoronavirinae; Betacoronavirus; Sarbecovirus; Severe acute respiratory syndrome-related coronavirus; Severe acute respiratory syndrome coronavirus 2
Submission	Registration date: 6-May-2020 FLDOH

Project Data:

Supplemental Content

Severe acute respiratory syndrome coronavirus 2
Severe acute respiratory syndrome coronavirus 2
SARS-CoV-2 Whole-Genome Sequencing

BioProject
Severe acute respiratory syndrome coronavirus 2 strain:Gamma
Severe acute respiratory syndrome coronavirus 2 strain:Gamma
Severe acute respiratory syndrome coronavirus 2 strain:Gamma Raw sequence reads

BioProject
SARS-CoV-2 point mutation and deletion spectra, and their association with diffe...
SARS-CoV-2 point mutation and deletion spectra, and their association with different disease outcome
The study shows that mutant spectra of SARS-CoV-2 from diagnostic samples differed in point mutation abundance and complexity, and that significantly larger values were recorded in virus from patients who developed mild COVID-19 symptoms. The abundance of low frequency mutations marks a difference with other RNA viruses, and it may slow down the response of SARS-CoV-2 to escape specific selective constraints such as drugs or antibodies.

BioProject
undefined
undefined
A comparison of high-throughput SARS-CoV-2 sequencing methods using COVID-19 patient samples

BioProject

Your browsing activity is empty.

Activity recording is turned off.